| RS2125026627 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2125026697 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2125029430 |
STAT1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency, Immunodeficiency 31B |
| RS2125032555 |
UNC80
|
Health Risk |
Pathogenic |
— |
| RS2125032674 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS2125034187 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2125035374 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2125035405 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS2125035511 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2125035588 |
XPC
|
Health Risk |
Likely pathogenic |
— |
| RS2125035636 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2125035850 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2125035926 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS2125035931 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS2125038490 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign familial hematuria, Autosomal recessive Alport syndrome |
| RS2125039231 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2125040590 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2125042060 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS2125043277 |
XPC
|
Health Risk |
Likely pathogenic |
— |
| RS2125045819 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2125046000 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2125046287 |
XPC
|
Health Risk |
Likely pathogenic |
— |
| RS2125048080 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS2125048104 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS2125048161 |
STAT1
|
Health Risk |
Likely pathogenic |
Immunodeficiency 31B, Immunodeficiency 31B |
| RS2125053499 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS2125058823 |
TAMM41
|
Health Risk |
Pathogenic |
Dysphagia, Bilateral ptosis |
| RS2125059701 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2125059924 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS2125060144 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2125062092 |
STAT1
|
Health Risk |
Pathogenic |
Chronic mucocutaneous candidiasis, Chronic mucocutaneous candidiasis |
| RS2125062317 |
STAT1
|
Health Risk |
Likely pathogenic |
Immunodeficiency 31B, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS2125062900 |
STAT1
|
Health Risk |
Pathogenic |
Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome, Immunodeficiency 31B |
| RS2125069514 |
FANCD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS2125071982 |
F13B
|
Health Risk |
Pathogenic |
Factor XIII, b subunit |
| RS2125072480 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2125072527 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2125075036 |
STAT1
|
Health Risk |
Pathogenic |
Immunodeficiency 31B, Immunodeficiency 31B |
| RS2125075054 |
STAT1
|
Health Risk |
Likely pathogenic |
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency, Immunodeficiency 31B |
| RS2125076610 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia |
| RS2125076614 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2125077465 |
COLQ
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS2125077559 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2125081509 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2125081666 |
COLQ
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2125081805 |
DNAJB2
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS2125082259 |
DNAJB2
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS2125082935 |
DNAJB2
|
Health Risk |
Likely pathogenic |
Neuronopathy, distal hereditary motor |
| RS2125085333 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS2125085542 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS2125086228 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2125086401 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS2125087894 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2125088445 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2125088498 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2125089059 |
COLQ
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2125089093 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome |
| RS2125089566 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2125093294 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2125093662 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2125093720 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2125094032 |
ASPM
|
Health Risk |
Likely pathogenic |
— |
| RS2125094632 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2125095183 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2125095244 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2125095313 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2125095360 |
ASPM
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2125096196 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2125096288 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2125096622 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2125096662 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2125096695 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2125100684 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2125103406 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS2125107452 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2125107857 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2125107877 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS2125111250 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125111475 |
SETD5
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2125112411 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2125113678 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2125113775 |
ASPM
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2125113873 |
ASPM
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Microcephaly 5 |
| RS2125114846 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS2125115880 |
SATB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental delay with dysmorphic facies and dental anomalies, Inborn genetic diseases |
| RS2125115970 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS2125122990 |
SATB1
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2125123160 |
COLQ
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS2125123167 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS2125123704 |
SATB1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2125124343 |
SUMF1
|
Health Risk |
Likely pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS2125124629 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2125124755 |
VHL
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2125124781 |
VHL
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2125124854 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2125124863 |
VHL
|
Health Risk |
Likely pathogenic |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2125125032 |
VHL
|
Health Risk |
Likely pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS2125125069 |
VHL
|
Health Risk |
Pathogenic |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2125125087 |
VHL
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2125125103 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |